We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$1.89T
AUM Growth
+$231B
Cap. Flow
+$19.1B
Cap. Flow %
1.01%
Top 10 Hldgs %
21.09%
Holding
8,715
New
423
Increased
3,809
Reduced
3,216
Closed
305

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.77B
2
MCK icon
McKesson
MCK
+$2.38B
3
SPCX
SpaceX
SPCX
+$2.3B
4
HONA
Honeywell Aerospace
HONA
+$2.05B
5
AMZN icon
Amazon
AMZN
+$1.37B

Sector Composition

Rank Sector Weight
1 Technology 24.63%
2 Financials 9.78%
3 Healthcare 7.32%
4 Industrials 7.25%
5 Consumer Discretionary 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTZ
8201
Intrusion
INTZ
$15.8M
$2 ﹤0.01%
2
-7,962
-100% -$6.29K
LEXX icon
8202
Lexaria Bioscience
LEXX
$18.2M
0
MGLD icon
8203
Marygold Companies
MGLD
$43.9M
$2 ﹤0.01%
1
MOGU
8204
MOGU Inc
MOGU
$15.9M
$2 ﹤0.01%
1
MRKR icon
8205
Marker Therapeutics
MRKR
$25.5M
$2 ﹤0.01%
2
NVVE
8206
DELISTED
Nuvve Holding Corp
NVVE
0
PMCB icon
8207
PharmaCyte Biotech
PMCB
$5.6M
$2 ﹤0.01%
2
+1
+100% +$1
SINT icon
8208
SiNtx Technologies
SINT
$10.1M
$2 ﹤0.01%
1
-17
-94% -$39
AACG
8209
ATA Creativity
AACG
$42.8M
$1 ﹤0.01%
1
CHGA
8210
Change Agents Corp
CHGA
$3.63M
$1 ﹤0.01%
3
-27,601
-100% -$10.7K
BNBX
8211
DELISTED
BNB PLUS CORP
BNBX
$1 ﹤0.01%
3
CLGN icon
8212
CollPlant Biotechnologies
CLGN
$5.48M
$1 ﹤0.01%
1
FTHM icon
8213
Fathom Holdings
FTHM
$23.5M
$1 ﹤0.01%
1
-5,500
-100% -$4.31K
INUV icon
8214
Inuvo
INUV
$11.5M
$1 ﹤0.01%
1
JOBY.WS
8215
DELISTED
Joby Aviation Warrants
JOBY.WS
$1 ﹤0.01%
3
RDHL
8216
Redhill Biopharma
RDHL
$3.71M
$1 ﹤0.01%
1
RKDA icon
8217
Arcadia Biosciences
RKDA
$1.17M
$1 ﹤0.01%
2
TOMZ icon
8218
TOMI Environmental Solutions
TOMZ
$13.8M
0
BTTC
8219
Black Titan Corp
BTTC
$5.71M
$1 ﹤0.01%
1
-1
-50% -$1
ACLX
8220
DELISTED
Arcellx
ACLX
-925,813
Closed -$106M
ADFI
8221
DELISTED
Anfield Dynamic Fixed Income ETF
ADFI
-526
Closed -$4.47K
ADPV icon
8222
Adaptiv Select ETF
ADPV
$181M
-1
Closed -$43
ADTX
8223
DELISTED
ADITXT INC
ADTX
-296
Closed -$7.83K
ADXN
8224
Addex Therapeutics
ADXN
$4.91M
-301
Closed -$1.89K
AESR icon
8225
Anfield US Equity Sector Rotation ETF
AESR
$248M
-397
Closed -$6.64K

Similar funds

Morgan Stanley's Q2 2026 Portfolio in Review

As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
  • Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
  • Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
  • Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
  • Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.